All Stories

  1. Gasdermin D Hypermethylation Inhibits Pyroptosis And LPS-Induced IL-1β Release From NK92 Cells
  2. Glatiramer Acetate, Dimethyl Fumarate, and Monomethyl Fumarate Upregulate the Expression of CCR10 on the Surface of Natural Killer Cells and Enhance Their Chemotaxis and Cytotoxicity
  3. Utilization of Dimethyl Fumarate and Related Molecules for Treatment of Multiple Sclerosis, Cancer, and Other Diseases
  4. Vitamin D3 and Monomethyl Fumarate Enhance Natural Killer Cell Lysis of Dendritic Cells and Ameliorate the Clinical Score in Mice Suffering from Experimental Autoimmune Encephalomyelitis
  5. Monomethyl fumarate augments NK cell lysis of tumor cells through degranulation and the upregulation of NKp46 and CD107a
  6. Oxidized Lipids and Lysophosphatidylcholine Induce the Chemotaxis, Up-Regulate the Expression of CCR9 and CXCR4 and Abrogate the Release of IL-6 in Human Monocytes
  7. American and British Administration Legacy in Iraq: Civilian Deaths and Development of Diseases
  8. Implications of chemokine receptors and inflammatory lipids in cancer
  9. Effects of Vitamin D3, Calcipotriol and FTY720 on the Expression of Surface Molecules and Cytolytic Activities of Human Natural Killer Cells and Dendritic Cells
  10. Oxidized lipids and lysophosphatidylcholine induce the chemotaxis and intracellular calcium influx in natural killer cells
  11. A One Year Follow-Up Study of Natural Killer and Dendritic Cells Activities in Multiple Sclerosis Patients Receiving Glatiramer Acetate (GA)
  12. On The Role of Natural Killer Cells in Neurodegenerative Diseases
  13. Interleukin-17 (IL-17) Expression Is Reduced during Acute Myocardial Infarction: Role on Chemokine Receptor Expression in Monocytes and Their in Vitro Chemotaxis towards Chemokines
  14. Identification of Human NK17/NK1 Cells
  15. Effects of Lysophospholipids on Tumor Microenvironment
  16. Expression and functional activity of chemokine receptors in glatiramer acetate–specific T cells isolated from multiple sclerosis patient receiving the drug glatiramer acetate
  17. Role of Chemokines in the Biology of Natural Killer Cells
  18. Splenic natural killer cell activity in two models of experimental neurodegenerative diseases
  19. Human resting CD16-, CD16+ and IL-2-, IL-12-, IL-15- or IFN-α-activated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and platelet-activating factor
  20. Compartmentalization of human natural killer cells
  21. Lysophospholipids and chemokines activate distinct signal transduction pathways in T helper 1 and T helper 2 cells
  22. Heptahelical Receptors for Lysolipids in Lymphocytes as Targets for Therapeutic Intervention
  23. Lysophosphatidic acid induces human natural killer cell chemotaxis and intracellular calcium mobilization
  24. Differential Utilization of Cyclic ADP-Ribose Pathway by Chemokines to Induce the Mobilization of Intracellular Calcium in NK Cells
  25. Intracellular Signalling Pathways Induced by Chemokines in Natural Killer Cells
  26. Role of the Heterotrimeric G Proteins in Stromal-Derived, Factor-1α-Induced Natural Killer Cell Chemotaxis and Calcium Mobilization
  27. Role of the Heterotrimeric G Proteins in Stromal-Derived Factor-1α-Induced Natural Killer Cell Chemotaxis and Calcium Mobilization
  28. CC chemokines induce the generation of killer cells from CD56+ cells
  29. IL-8 Induces Calcium Mobilization in Interleukin-2-activated Natural Killer Cells Independently of Inositol 1,4,5 Trisphosphate
  30. Guanine nucleotide binding proteins mediate the chemotactic signal of transforming growth factor-β1 in rat IL-2 activated natural killer cells
  31. The IgA Receptors of T560, a Murine IL-4-Secreting, CD5−, IgG2Aκ+, BrMRBC-Binding B Lymphomaa
  32. T560: an (H-2b × H-2a) F1 hybrid, phosphorylcholine (PC)-binding, murine B cell lymphoma that bears receptors for lgA and lgG, Presents antigen and secretes IL-4
  33. Sensitivity of receptors for IgA on T560, a murine B lymphoma, to phorbol myristate acetate and to phosphatidylinositol-specific phospholipase C
  34. Fate of intravenously administered rat lymphokine-activated killer cells labeled with different markers
  35. In vivo distribution and tissue localization of highly purified rat lymphokine-activated killer (LAK) cells
  36. Con A-Propagated, Auto-Reactive T Cell Clones that Secrete Factors Promoting High IgA Responses
  37. Detectionin vivo 6 hours after immunization of a mediator with possible antisuppressor activity
  38. Interleukin-2 Is Central for the Development of Rat LAK Cells: Regulation by Various Cytokines
  39. Effect of Carbohydrates on the in vivo Migration of Purified LAK Cells
  40. Proteolytic Enzymes of Adherent Rat Lymphokine-Activated Killer Cells1